FETO-MATERNAL RISK FACTOR ASSOCIATED TO THE MODERATELY AND EXTREMELY OBESE PREGNANT WOMAN IN COMPARISON TO THE NORMAL WEIGHTED PREGNANT CASES (PRIMIGRAVIDA AND MULTIGRAVIDA CASES): A COMPARATIVE COHORT RESEARCH

Journal Title: Indo American Journal of Pharmaceutical Sciences - Year 2018, Vol 5, Issue 5

Abstract

Objective: The comparison of the adverse Feto-maternal outcomes in both the groups of Normal and overweight pregnant woman was the objective of this particular research. Methods: Design of the research was comparative cohort, which was completed in the time span of November, 2016 to October, 2018 (Mayo Hospital, Lahore) on a sample of 200 gravid ladies. Sample was divided into two main groups named as overweight and normal pregnant women of hundred cases each. Sample was comprised of pregnant women having gestational age in the range of 08 weeks – 40 weeks. Overweight and normal cases were categorized respectively as (BMI 25 – 29.9 Kg/m2) and (BMI of 18.5 – 24.9), normal cases were taken as controls. Feto-maternal outcomes were compared through Chi-square test and the pvalue was taken as (< 0.05). Results: Women selected for the research were in the age bracket of 30 – 45 years with a mean age of (30 ± 4.1 years). High frequency of pre-eclampsia was observed in overweight women in comparison to the normal group (27% vs 9%), gestational diabetes mellitus (DM) (22% vs 5%), PIH (24% vs 8%), Caesarean section (44% vs 16%), prolonged labor (4% vs 6%), Postpartum Hemorrhage (5% vs 2%) and Wound infection (3% vs 2%). The significant P-value was taken as (< 0.001). In terms of fetal complications in both the groups when compared were as Early neonatal death (11% vs 1%), Still birth (13% vs 2%), NICU admission (47% vs 10%) and shoulder dystocia (5% vs 1%). Except the incidence of shoulder dystocia outcomes were statistically significant. Conclusion: It is concluded that deleterious effects are related to the incidence of obesity on the Feto-maternal outcomes. Key Words: Outcomes, Controls, Pregnant Overweight Women and Adverse Feto-maternal.

Authors and Affiliations

Keywords

Related Articles

A BRIEF REVIEW ON WEGENER’S GRANULOMATOSIS AND ITS TREATMENT

Wegener's Granulomatosis (WG) which is otherwise called as Granulomatosis with polyangiitis (GPA) is an uncommon multi system autoimmune diseases, which is exceptionally connected with Anti-Neutrophil Cytoplasmic Antibod...

A CLINICAL STUDY ON ANTIBACTERIAL ACTIVITY OF TOOTHPASTES AGAINST DENTAL PLAQUE AND CARIES CAUSING BACTERIA

The present study was carried out to evaluate antibacterial activity of toothpastes, which were available in local market. A total 15 samples were collected for isolation of cariogenic bacteria. The bacterial strains wer...

PREPARATION AND CHARACTERISATION OF TORSEMIDE MICROCAPSULES

Hypertension (HTN or HT), also known as high blood pressure (HBP), is a long term medical condition in which the blood pressure in the arteries is persistently elevated. Microencapsulation is a process of applying relati...

FORMULATION AND IN VITRO EVALUATION OF NIFEDIPINE FLOATING MATRIX TABLETS BY USING NATURAL POLYMERS

In the present research work gastro retentive floating matrix formulation of Nifedipine by using Natural polymers were developed. Initially analytical method development was done for the drug molecule. Absorption maxima...

THE BORDERING AREAS (NINE AREAS OF PANJGUR DISTRICT) ISSUE OF PAKISTAN ABOUT HUMAN MALARIA PREVALENCE: A CROSS-SECTIONAL RESEARCH OF MALARIA PARASITES IDENTIFICATION IN BLOOD SLIDES

Objective: The objective of research was the malaria infection prevalence identification in the population of Southern Western Pakistan (Panjgur). Methods: Our research was by design cross-sectional and it identified the...

Download PDF file
  • EP ID EP292403
  • DOI -
  • Views 293
  • Downloads 0

How To Cite

(2018). FETO-MATERNAL RISK FACTOR ASSOCIATED TO THE MODERATELY AND EXTREMELY OBESE PREGNANT WOMAN IN COMPARISON TO THE NORMAL WEIGHTED PREGNANT CASES (PRIMIGRAVIDA AND MULTIGRAVIDA CASES): A COMPARATIVE COHORT RESEARCH. Indo American Journal of Pharmaceutical Sciences, 5(5), 4317-4323. https://europub.co.uk/articles/-A-292403